Is Maternal Use of Paracetamol during Pregnancy Associated with Anogenital Distance in Male Newborns? The Results from the NELA Birth Cohort

• Published in: International journal of environmental research and public health Vol. 18; no. 12; p. 6338
• Main Authors: Navarro-Lafuente, Fuensanta, Arense-Gonzalo, Julián, Adoamnei, Evdochia, Prieto-Sánchez, María, Sánchez-Ferrer, María, García-Marcos, Luis, Morales, Eva, Mendiola, Jaime, Torres-Cantero, Alberto
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 11.06.2021; MDPI
• Subjects: Analgesics; Anogenital; Asthma; Childbirth & labor; Endocrine disruptors; Evaluation; Fetuses; Gestational age; Gestational diabetes; Hospitals; Hypertension; Males; Mothers; Neonates; Nutrition; Paracetamol; Pregnancy; Regression analysis; Social classes; Standard deviation; Variables; Womens health
• ISSN: 1660-4601; 1661-7827; 1660-4601
• DOI: 10.3390/ijerph18126338

Paracetamol is the one of the most commonly used medications during pregnancy. However, its potential antiandrogenic effect has been suggested. The objective of this study was to evaluate associations between maternal paracetamol use during pregnancy and anogenital distance (AGD) in male newborns from a Spanish birth cohort. The study included two hundred and seventy-seven mother-male child pairs with self-reported paracetamol use and frequency during each trimester of pregnancy. AGD measurements were taken employing standardized methods. The associations between maternal paracetamol use and AGD measures were evaluated using linear regression models, adjusting for potential confounders and covariates. Overall, 61.7% of pregnant women consumed paracetamol at any time of pregnancy with an average of 9.43 (SD = 15.33) days throughout pregnancy. No associations between the maternal use of paracetamol or its frequency and AGD measures among different trimesters or during the whole pregnancy were found in the adjusted final models. A non-differential misclassification error may have occurred—the recall of paracetamol intake independent of AGD measurements—introducing bias towards the null hypothesis. Nevertheless, the current evidence suggests that paracetamol might have a potential antiandrogenic effect especially in the early stages of fetal development. Thus, it would be highly recommendable to pursue further studies to elucidate the potential effects of paracetamol in human perinatal health and its use among pregnant women.